Tag: SKVI

StockGuru

Breaking News: Skinvisible Pharmaceuticals $SKVI

Skinvisible Signs Global Licensing Agreement for Its Cannabis Products Invisicare Enhances the Delivery of Topical Medical Marijuana in New Product Line LAS VEGAS, NV – September 15, 2016 / Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI), developers of patented Invisicare® polymer delivery systems, announces it has licensed the exclusive world rights to its topical and transdermal cannabis products formulated with Invisicare to CannaSkin, LLC, a cannabis product licensing company with international contacts in the medical marijuana industry. CannaSkin has the exclusive license to manufacture, market and sub-license Skinvisible’s new cannabis products. Their targets will initially include facilities in the 25 US jurisdictions currently

Blog

Skinvisible’s Kintari is the one place you can get Invisicare products

The Power of Invisicare   For every cream you apply to your skin, whether it contains an active drug ingredient or an ingredient from nature, it is extremely important how those ingredients are delivered to the skin and how long they stay on the skin. Invisicare skin delivery technology with over fifteen worldwide patents, delivers both. Invisicare has been granted patents for its ability to stabilize active ingredients while research has also proven that Invisicare binds products to the skin while resisting both wash-off and rub-off. This means that ingredients remain on your skin, giving them the required time to

Blog

Kintari’s President & CEO Terry Howlett – New Video

Skinvisible Pharmaceuticals Inc. (OTCQB: SKVI) has launched its key subsidiary, Kintari.com. What follows is an introductory video from CEO Terry Howlett: What is Kintari?  We have this from Kintari.com that explains it more fully: We are an exciting new company with unique skin care products made with our patented Invisicare® skin care delivery technology. Invisicare is the foundation to all our products formulas – it is the delivery system that not only delivers our active ingredients onto the skin but also the system that holds them on there. Invisicare is the result of over fifteen years of research and development

Blog

The Kintari Team from Skinvisible $SKVI #Kintari #Skinvisible

Skinvisible Inc. (OTCQB: SKVI) earlier this year announced its new subsidiary Kintari. As this year comes to a close, it is critically important to get to know about Kintari. While everything we have always liked about Skinvisible continues to be important and very valid reasons to buy this stock at the current levels, Kintari is huge. This is where some serious growth can come in for 2015. We’re going to look at this in detail, but let’s start with the team as it now shows on the Kintari site: THE KINTARI TEAM Kintari brings you a team of seasoned direct

Blog

Big for 2015: Skinvisible’s Kintari Subsidiary

What is Kintari? We are an exciting new company with unique skin care products made with our patented Invisicare® skin care delivery technology. Invisicare is the foundation to all our products formulas – it is the delivery system that not only delivers our active ingredients onto the skin but also the system that holds them on there. Invisicare is the result of over fifteen years of research and development of pharmaceutical and cosmeceutical products. Unique and effective products are just the beginning for this world class opportunity. To create a business opportunity that cannot be matched, the team at Kintari

Blog

Tuesday Trade Alert: Up 147.5% from Recent Lows, Skinvisible (SKVI) is Clearly Breaking Out

. We see yet another 52 week high for Skinvisible Inc. (OTCQB: SKVI) Yesterday’s $0.099 is another 52 Week High! Let’s look at their New Subsidiary, Kintari: What is Kintari? The answer from the most recent press release from SKVI: The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients are powered by our patented Invisicare® technology, providing consumers with

Alert

52 Week High Alert for Skivisible Inc. (SKVI) as Kintari Gets Closer to Launch

Everything is coming together for Skinvisible Inc. (OTCQB: SKVI) as it nears its official Kintari Launch. We seen the stock more than double in recent weeks from its low point. The stock’s momentum is catapulting the share price to nearly triple now. Today’s high is $0.0849 Let’s put that in perspective: That’s 13.96% up today over yesterday’s close. That’s 112.25% over the low this month. That’s 121.67% over the low from recent weeks. What is Kintari? The answer from the most recent press release from SKVI: The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight

Blog

Breaking News from Skinvisible Inc. and its Kintari Subsidiary with the Announcement Naming Dean Aldridge as Master Distributer

Skinvisible’s Subsidiary Kintari Announces Network Marketing Expert Dean Aldridge as Master Distributor Kintari Launching Patented Skin Care Product Line Las Vegas, NV– October 29, 2014 – Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) – through its wholly owned subsidiary Kintari International Inc., makers of patented “Youth Renewed” skin care products – is pleased to announce the selection of R. Dean Aldridge in the key role of Master Distributor. Dean will spearhead distributor expansion and development globally. “We are very pleased to have Dean Aldridge, a world class marketer and sales leader, as our Master Distributor for Kintari,” said Terry Howlett, President of

Alert

New 52 Week High for Client Skinvisible Inc. $SKVI – Nearly Doubled in Two Weeks

Another 52 Week High for Skinvisible Our client Skinvisible Inc. (OTCQB: SKVI) has had huge news in the past two months. We have covered the Company most of the past four years, and we signed a renewed agreement to handle investor relations on an ongoing basis in the middle of July. We give all credit to the Company (and not ourselves) as the stock is now up 108% since we started with them again.  The reason for their success is really several reasons: The fundamentals of the Company. No preferred shares or anything that would undermine shareholder equity.  The products

Breaking News

Our Profile Stock and Client Skinvisible Inc. $SKVI Hits 52 Week High Yesterday as it Moves Forward with Kintari

Yesterday, Skinvisible Inc. (OTCQB: SKVI) established a new 52 week high!   It did this intraday yesterday as it reached $0.0724.  What’s going on with Skinvisible? Well, Kintari®, of course! Let’s look at some of our recent coverage of Kintari. It’s coming soon, so get ready.  HERE ARE THE TWO PRESS RELEASES THAT ANNOUNCED KINTARI:  FROM AUGUST 7TH:  SKINVISIBLE ANNOUNCES EXPANSION WITH A NEW SCIENTIFIC SKINCARE COMPANY “PREMIUM INVISICARE POWERED KINTARI(TM) PRODUCTS GO TO MARKET” Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) today announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products

Breaking News

Skinvisible Pharmaceuticals $SKVI adds Key People to #Kintari

Skinvisible and Kintari Expands Team of Experts Key Direct Sales and Production Staff Added Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari, is pleased to announce the addition of Rob Barnes as Director of Sales. Rob will lead Kintari’s sales globally. Rob BarnesKintari’s Director of Sales Rob brings over two decades of direct sales experience to Kintari’s already strong team of experienced sales, marketing and product development personnel. He will be responsible for developing the initial sales team and meeting aggressive sales objectives utilizing an independent sales force. The direct sales industry is nothing new to Rob

Breaking News

Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) $SKVI #Kintari

Skinvisible Announces Expansion With a New Scientific Skincare Company “Premium Invisicare Powered Kintari(TM) Products Go to Market” Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products powered by the company’s patented Invisicare® technology. As part of the Company’s strategic focus on revenue generation and creating shareholder value, Kintari will be a direct sales company that will launch products initially in the United States and Canada. The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. The Kintari YR

Closing Bell Alert

Skinvisible’s $SKVI Polymer: Why it’s Critical and How it’s IP Protected

This question comes up with SKVI: Why is Skinvisible Pharmaceutical’s (OTCQB: SKVI) so critical? What is special about it? In Simple Words:  When it comes to Skinvisible and their Invisicare polymer, this polymer (in simple words) is a substance that binds an active ingredient to the skin to increase the active ingredient’s effectiveness.  If you are using it to keep a medicine in place or to keep an antiseptic in place, the better the polymer the more likely the polymer will bind to the skin and make the active ingredient effective.  What makes Skinvisible’s polymer so good is that it is

Live Alert

Skinvisible’s Kintari $SKVI – The Story Behind This New Network Marketing Subsidiary

We are going to be looking closely this week at the Skinvisible Pharmaceuticals (OTCQB: SKVI).  We have introduced you to their new subsidiary, Kintari, before the Labor Day break. As we look into this more closely, we will explain why the unique polymers that Skinvisible has developed and patented are used by many products already sold all over the world. Many are pharmaceuticals. Others are what are called “cosmeceuticals.” Those are defined by some as “Cosmeceuticals are cosmetic products with biologically active ingredients purporting to have medical or drug-like benefits.” That definition can be found in WikiPedia.  Here are the

Blog

Network Marketing Competitors: Skivisible Pharmaceuticals’ $SKVI new Kintari subsidiary

With Skivisible Pharmaceuticals’ (OTCQB: SKVI) new Kintari subsidiary, there is a huge precedent for success with skin products and network marketing on the public markets. Some of the biggest names on Wall Street use this business model. More importantly than that, they achieve success using their network to lower the cost of the acquisition of new customers.  That increases margins substantially. That is why some of these companies are so big. How big? Let’s look at the top five and their market caps: Herbalife Ltd. (NYSE: HLF) – – Market Cap: $4.5B Nu Skin Enterprises Inc. (NYSE: NUS) – – Market Cap: $2.92B

Blog

Skinvisible $SKVI is Investing in long Term Growth with its Network Marketing Subsidiary Kintari

Skinvisible Pharmaceuticals (OTCQB: SKVI) is investing in long term growth with its network marketing subsidiary Kintari. It is a natural that Skinvisible products play a major role in network marketing. After all when you look at some of the biggest names in networking marketing, you see companies that have skincare products. What makes Skinvisible in an excellent position to make a meaningful impact in this arena is that the Company has a very unique and patent protected polymer that makes the application of skincare products so much better. More on that this week – see below for details. Kintari is

Blog

Skinvisible $SKVI #Kintari Recently Featured in an article by Andrew McDougall on CosmeticDesign.com, a Leading Industry News Site

Featured on Industry Leading Website Skinvisible Pharmaceuticals (OTCQB: SKVI) was featured on CosmeticDesign.com with the announcement of SKVI’s new subsidiary, Kintari. Kintari is a network marketing subsidiary that will complement everything else SKVI does.  Here is the article:   Skinvisible expands with new anti-aging subsidiary By Andrew McDougal Quoting from the article: “Skinvisible will take further steps into the skin care field after launching a new wholly-owned subsidiary called Kintari that will market a premium line of products powered by the company’s patented Invisicare technology.” READ THE FULL ARTICLE HERE:   http://www.cosmeticsdesign.com       John Pentony now represents Skinvisible Pharmaceuticals, Inc.

Blog

Skinvisible $SKVI Appoints Rob Barnes as Kintari Director of Sales

Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to market. Many pharmaceutical companies across the world use the exclusive polymers that have created the success.  Kintari is above and beyond all of that. It’s new, and it’s new because there is so much potential here.  WHAT IS KINTARI? Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products powered by the Company’s patented Invisicare® technology. As part of

Blog

More About Skinvisible $SKVI and Kintari, The New Network Marketing Subsidiary

Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to market. Many pharmaceutical companies across the world use the exclusive polymers that have created the success.  Kintari is above and beyond all of that. It’s new, and it’s new because there is so much potential here.  WHAT IS KINTARI? Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products powered by the Company’s patented Invisicare® technology. As part of